3-184711428-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_022149.5(MAGEF1):āc.394G>Cā(p.Glu132Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000107 in 1,614,084 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_022149.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MAGEF1 | NM_022149.5 | c.394G>C | p.Glu132Gln | missense_variant | 1/1 | ENST00000317897.5 | NP_071432.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MAGEF1 | ENST00000317897.5 | c.394G>C | p.Glu132Gln | missense_variant | 1/1 | NM_022149.5 | ENSP00000315064 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000164 AC: 25AN: 152190Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000123 AC: 31AN: 251492Hom.: 0 AF XY: 0.000103 AC XY: 14AN XY: 135918
GnomAD4 exome AF: 0.000101 AC: 148AN: 1461894Hom.: 0 Cov.: 90 AF XY: 0.0000894 AC XY: 65AN XY: 727248
GnomAD4 genome AF: 0.000164 AC: 25AN: 152190Hom.: 0 Cov.: 33 AF XY: 0.000134 AC XY: 10AN XY: 74356
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 06, 2022 | The c.394G>C (p.E132Q) alteration is located in exon 1 (coding exon 1) of the MAGEF1 gene. This alteration results from a G to C substitution at nucleotide position 394, causing the glutamic acid (E) at amino acid position 132 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at